Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTC
3176
LTC Properties
LTC
$2.31B
| $514K | ﹤0.01% |
13,371
-962
| -7% | -$36.5K |
|
|
JBS
3177
JBS N.V.
JBS
$38.1B
| $514K | ﹤0.01% |
43,370
+27,984
| +182% | +$409K |
|
3178
MiMedx Group
MDXG
$682M
| $513K | ﹤0.01% |
133,270
-54,189
| -29% | -$198K |
|
3179
Western New England Bancorp
WNEB
$280M
| $513K | ﹤0.01% |
35,862
-1,687
| -4% | -$23K |
|
3180
Insperity
NSP
$1.83B
| $511K | ﹤0.01% |
12,380
+5,558
| +81% | +$182K |
|
3181
Madison Square Garden
MSGE
$3.74B
| $510K | ﹤0.01% |
6,311
-2,324
| -27% | -$159K |
|
3182
Universal Technical Institute
UTI
$1.12B
| $510K | ﹤0.01% |
11,924
-3,946
| -25% | -$152K |
|
3183
Defiance Quantum ETF
QTUM
$5.73B
| $510K | ﹤0.01% |
3,082
+2,474
| +407% | +$356K |
|
3184
Amphastar Pharmaceuticals
AMPH
$1.11B
| $509K | ﹤0.01% |
25,217
+3,934
| +18% | +$79.4K |
|
3185
CALL
Global X MLP & Energy Infrastructure ETF
MLPX
$3.46B
| $508K | ﹤0.01% |
+6,900
| New | +$507K |
|
3186
Vanguard International Dividend Appreciation ETF
VIGI
$8.97B
| $508K | ﹤0.01% |
5,440
+1,170
| +27% | +$108K |
|
|
EFSI
3187
Eagle Financial Services Inc
EFSI
$247M
| $508K | ﹤0.01% |
12,251
-396
| -3% | -$15.5K |
|
3188
Fate Therapeutics
FATE
$282M
| $508K | ﹤0.01% |
187,989
+114,993
| +158% | +$213K |
|
3189
Intapp
INTA
$2.76B
| $507K | ﹤0.01% |
20,112
-31,337
| -61% | -$714K |
|
3190
NB Bancorp
NBBK
$990M
| $506K | ﹤0.01% |
23,951
+852
| +4% | +$17.5K |
|
3191
BayCom
BCML
$337M
| $505K | ﹤0.01% |
15,364
-835
| -5% | -$25.6K |
|
3192
Great Southern Bancorp
GSBC
$860M
| $505K | ﹤0.01% |
6,443
+1,383
| +27% | +$97.5K |
|
3193
Carter's
CRI
$1.15B
| $504K | ﹤0.01% |
12,245
-17,310
| -59% | -$655K |
|
|
FNGU
3194
MicroSectors FANG+ 3x Leveraged ETNs due Feb 17 2045
FNGU
$2.86B
| $504K | ﹤0.01% |
19,600
| – | – |
|
|
JBIO
3195
Jade Biosciences
JBIO
$917M
| $503K | ﹤0.01% |
22,634
-2,026
| -8% | -$42.3K |
|
3196
Home Bancorp
HBCP
$532M
| $502K | ﹤0.01% |
7,326
+5,932
| +426% | +$383K |
|
3197
CALL
Workday
WDAY
$45.7B
| $502K | ﹤0.01% |
4,100
-49,200
| -92% | -$6.23M |
|
3198
Teekay Tankers
TNK
$3.26B
| $500K | ﹤0.01% |
7,706
-2,612
| -25% | -$197K |
|
3199
Vanda Pharmaceuticals
VNDA
$305M
| $500K | ﹤0.01% |
81,650
+841
| +1% | +$5.49K |
|
3200
Urban One Class D
UONEK
$17.1M
| $500K | ﹤0.01% |
108,392
-11,267
| -9% | -$56.2K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.